Visible benefits on ischemic patients: Cardiac imaging
About the event
In this conference, the doctor Luis Antonio Machado presents a revision of evidence that support the use of Trimetazidine 80mg for the upbringing of patients that suffer from coronary chronic syndrome.
The doctor explains its metabolic effect, considering a synergy and complimentary action with Beta blockers, offering a significative improvement on the ejection fraction and the LVLGS (Left Ventricular Longitudinal Global Strain) among others. For more information, watch the video ahead:
CAC-05/23-DM-182- For exclusive use of Healthcare professionals
Don't miss our next events!
Subscribe to our newsletter to receive invitations to upcoming events
You can unsubscribe at any time by clicking on the link in our emails.